Compare MDU & ADMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MDU | ADMA |
|---|---|---|
| Founded | 1924 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Mining & Quarrying of Nonmetallic Minerals (No Fuels) | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.3B | 3.6B |
| IPO Year | 1994 | 2012 |
| Metric | MDU | ADMA |
|---|---|---|
| Price | $20.89 | $16.81 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | $22.00 | ★ $28.50 |
| AVG Volume (30 Days) | 1.8M | ★ 2.4M |
| Earning Date | 05-07-2026 | 05-15-2026 |
| Dividend Yield | ★ 2.71% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.93 | 0.60 |
| Revenue | ★ $1,875,066,000.00 | $42,219,783.00 |
| Revenue This Year | $6.87 | $26.71 |
| Revenue Next Year | $5.89 | $21.78 |
| P/E Ratio | ★ $22.21 | $25.72 |
| Revenue Growth | 6.66 | ★ 43.85 |
| 52 Week Low | $15.04 | $13.50 |
| 52 Week High | $21.49 | $25.67 |
| Indicator | MDU | ADMA |
|---|---|---|
| Relative Strength Index (RSI) | 59.50 | 53.49 |
| Support Level | $20.09 | $16.39 |
| Resistance Level | $21.23 | $17.90 |
| Average True Range (ATR) | 0.42 | 0.82 |
| MACD | 0.02 | 0.07 |
| Stochastic Oscillator | 86.48 | 85.25 |
MDU Resources Group Inc operates in three business segments, which include the electric segment, which generates, transmits, and distributes electricity in Montana, North Dakota, South Dakota, and Wyoming; The natural gas distribution segment distributes natural gas in those states, as well as in Idaho, Minnesota, Oregon, and Washington; The pipeline segment provides natural gas transportation and underground storage services through a regulated pipeline system in the Rocky Mountain and northern Great Plains regions of the United States. The majority of its revenues is generated from the Natural Gas distribution segment.
ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing, and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing, which generates maximum revenue, Plasma Collection Centres, and the corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling & packing services. The company derives maximum revenue from the United States.